TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 0 | 0 | -1 | -2 | 3 | 11 | 3 |
| P | %wins | 100 | 100 | 50 | 50 | 50 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/10/05 17:31 | 11/16/04 | GAM | General American Investors Co Inc | DE | Fund | CEF | Closed-End Funds | Altschul Arthur G Jr | NY | D | P | 92 | 30.71 | 1 | 3 | 1 | 306 | I | 30 | 4 | 6 | 4 | -1 | -2 | -3 | -1 | 0 | 0 | 3 | 2 | 9 | 21 | |
4/19/04 15:57 | 1/27/04 | GAM | General American Investors Co Inc | DE | Fund | CEF | Closed-End Funds | Altschul Arthur G Jr | NY | D | P | 20 | 30.70 | 1 | 1 | 0 | 281 | I | 1 | 28 | 9 | 2 | -2 | 3 | -1 | 0 | 0 | 0 | -4 | -5 | -4 | 0 | |
2/5/04 15:52 | 12/31/03 | VLTS | Valentis Inc | DE | Health | BioPrd | Biological Products, (No Diag | Altschul Arthur G Jr | NY | T | P.ad | 250 | 2.05 | 0 | 122 | 9 | 1,551 | I | |||||||||||||||
1/5/04 21:50 | 12/31/03 | VLTS | Valentis Inc | DE | Health | BioPrd | Biological Products, (No Diag | Altschul Arthur G Jr | NY | T | P | 250 | 2.05 | 0 | 122 | 9 | 1,551 | I | |||||||||||||||
9/26/03 12:58 | 9/24/03 | GAMPR | General American Investors Co Inc | DE | Fund | CEF | Closed-End Funds | Altschul Arthur G Jr | NY | D | P | 2,555 | 25.00 | 0 | 102 | New | 102 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |